kTMP in Chronic Stroke

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 100 participants.

Also called NCT07277595

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07277595
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07277595. Randomized; double masking; primary purpose treatment. Start 2026-07-01 (anticipated); primary completion 2030-08-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
kTMP in Chronic Stroke
Acronym
KULMINATE
Condition
Stroke
Condition
Chronic Stroke Patients
Condition
Arm Weakness as a Consequence of Stroke
Intervention (Device)
kTMP sham stimulation 9 weeks + active stimulation 9 weeks
Intervention (Device)
kTMP 18 weeks
Lead sponsor
University of California, San Francisco (class: other)
Collaborator
National Institute of Neurological Disorders and Stroke (NINDS) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct07277595
Content hash
461d19ba44aaf6f98c8f77a2d55d42632d628b74105bcc072905c601cc1f7c9f